This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2002 Apr 15;20(8):1962-4.

doi: 10.1200/JCO.2002.20.8.1962.

Epirubicin, cisplatin, and fluorouracil in gastric and esophageal cancer: a step ahead?

PMID: 11956251
DOI: 10.1200/JCO.2002.20.8.1962

Editorial

Epirubicin, cisplatin, and fluorouracil in gastric and esophageal cancer: a step ahead?

David H Ilson. J Clin Oncol. 2002.

. 2002 Apr 15;20(8):1962-4.

doi: 10.1200/JCO.2002.20.8.1962.

Author

PMID: 11956251
DOI: 10.1200/JCO.2002.20.8.1962

No abstract available

PubMed Disclaimer

Comment on

Prospective randomized trial comparing mitomycin, cisplatin, and protracted venous-infusion fluorouracil (PVI 5-FU) With epirubicin, cisplatin, and PVI 5-FU in advanced esophagogastric cancer.
Ross P, Nicolson M, Cunningham D, Valle J, Seymour M, Harper P, Price T, Anderson H, Iveson T, Hickish T, Lofts F, Norman A. Ross P, et al. J Clin Oncol. 2002 Apr 15;20(8):1996-2004. doi: 10.1200/JCO.2002.08.105. J Clin Oncol. 2002. PMID: 11956258 Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

Supplementary concepts

Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Medical
- MedlinePlus Health Information